Pillar Biosciences' Unattributed VC Round

Pillar Biosciences raised a round of funding on May 11, 2016. Investors include ORI Capital.

Pillar Biosciences leverages patent-pending targeted sequencing technology platform and a proprietary data analysis toolkit to provide a targeted sequencing method for NGS-based oncology testing.…

Articles about Pillar Biosciences' Unattributed VC Round: